Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Akeso, Inc. ( (HK:9926) ) is now available.
Akeso, Inc. has announced that its board of directors will meet on March 30, 2025, to consider and approve the company’s annual results for the year ending December 31, 2024. This meeting is crucial for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the upcoming year.
More about Akeso, Inc.
Akeso, Inc. is a company incorporated in the Cayman Islands, operating within the healthcare industry. The company is involved in the development and commercialization of pharmaceutical products, focusing on innovative therapies.
YTD Price Performance: 15.16%
Average Trading Volume: 8,229,497
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$62.74B
See more data about 9926 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money